Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT02123355
Other study ID # SPPHA01
Secondary ID
Status Not yet recruiting
Phase Phase 4
First received April 20, 2014
Last updated April 24, 2014
Start date August 2014
Est. completion date August 2014

Study information

Verified date April 2014
Source Shaanxi Provincial People's Hospital
Contact n/a
Is FDA regulated No
Health authority China: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

The incidence of postoperative cognitive dysfunction (POCD) is high and POCD affect the life quality and the prognosis of patients. Geriatrics is the independent risk factor of POCD, and POCD is also correlated with many other factors such as type of surgery, the duration of anesthesia and the anesthesia drugs used et al. So, the prevention and treatment of POCD in geriatrics is important.

Dexmedetomidine is found to have the effect of neuro-protection, but it is controversy whether Dexmedetomidine has the effect of neuro-protection in geriatrics, especially the prolonged surgery.

The purpose of this study is to explore the effect of Dexmedetomidine to the cognitive function at prolonged surgery in geriatrics in geriatrics.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 80
Est. completion date August 2014
Est. primary completion date August 2014
Accepts healthy volunteers No
Gender Both
Age group 65 Years and older
Eligibility Inclusion Criteria:

1. Written informed consent

2. Scheduled for elective abdominal surgery

3. Age=65 yrs

4. Weight is within the range of ±20% of standard weight [standard weight=Height(cm)-80)×70? for male and(Height(cm)-70)×60?] for female

5. American society of anesthesia classification I~III

6. Expected time of surgery is more than 4 hours -

Exclusion Criteria:

1. Systolic blood pressure=180 mm Hg or <90 mm Hg,diastolic blood pressure=110 mm Hg or < 60 mm Hg;

2. Serious cardiac,liver,kidney,lung, endocrine disease or sepsis.

3. Allergy to trial drug or other contraindication;

4. Difficult airway occurred before,or difficult airway possibly occurred and difficult to extubation

5. History of mental illness and cerebral vascular disease

6. History of unstable angina or myocardial infarction

7. Education level<7 yrs

8. Factors existed that affect cognition assessment such as language, visual sense,auditory sense disorders.

9. Abuse of narcotic analgesia or suspected;

10. Neuromuscular diseases;

11. Mentally unstable or has a mental illness;

12. Pregnant or breast-feeding women;

13. Attended other trial past 30 days; -

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Induction of anesthesia
Midazolam 0.05 mg/kg?Propofol 1.0 mg/kg?Sufentanyl 3µg/kg?Victracurium 0.1 mg/kg sequential intravenous injection
Procedure:
Intubation
After muscle relaxed and loss of eyelash reflex of the patients, intubation is done,then mechanical ventilation is performed, and maintain the PETCO2?35~40 mmHg,pulse oxygen saturation is more than 95%.
Drug:
Sevoflurane, remifentanil ,vecuronium
Sevoflurane(1%-2%)is inspirated, and remifentanil 0.1-0.5µg/kg//min is continuously pumped,vecuronium 0.03 mg/kg is injected intermittently.
Dexmedetomidine
Dexmedetomidine is given at 0.5µg/kg/h by continuous infusion and is stopped to given 30 minutes before the surgery is over.
Placebo
Normal saline is given at 0.5µg/kg/h by continuous infusion and is stopped to given 30 minutes before the surgery is over.

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Shaanxi Provincial People's Hospital Chinese Medical Association

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline in cognitive function at 7 days Modified Newman scale to assess the cognitive function, including five tests.
The quiet environment, enough daylight, no disturb is needed when the modified Newman scale is done. All the five tests are finished within 30 min.
all the score of each test of all the patients assessed before the surgery is calculated, then get the standard variation, the score of each subject of each test is compared with the standard deviation, if one or more stand deviation decrease, then the cognitive function is considered as deterioration .
When 2 or more of the tests is considered as deterioration, then the patients is diagnosed as Post Operation Cognitive Dysfunction (POCD).
Baseline, the 7th day after the surgery Yes
Secondary Brain injury assessment 2 ml blood sample is collected at 8 time points including before surgery,the right moment,2 hr and 4 hr after the induction, the right moment,12,24 and 48 hours after the surgery.
The serum level of C-reaction protein(CRP),tumor necrosis factor(TNF-a)?interleukin-6(IL-6),interleukin-10(IL-10) is tested using immunohistochemical double antibody sandwich enzyme-linked immunosorbent assay (ELISA)
From entering the operating room to 48 hours after the surgery Yes
Secondary Inflammatory responsive assessment 2 ml blood sample is collected at 8 time points including before surgery,the right moment,2 hr and 4 hr after the induction, the right moment,12,24 and 48 hours after the surgery.
The concentration of protein S100B(S100B)and neuron specific enolase (NSE)in serum is tested using immunohistochemical double antibody sandwich enzyme-linked immunosorbent assay (ELISA).
From entering the operating room to 48 hours after the surgery Yes
Secondary Heart rate Heart rate are monitored every 15 min from the induction of anesthesia to the right moment of extubation. From the induction of anesthesia to the right moment of extubation, up to 1 day. Yes
Secondary Depth of anesthesia Bispectral index(BIS) monitor are performed every 15 min from the induction of anesthesia to the right moment of extubation. From the induction of anesthesia to the right moment of extubation, up to 1 day. No
Secondary Recovery of anesthesia Time of anesthetic ceased,time of call to open eyes,time to extubation, time to leave the PACU are recorded. From the induction of anesthesia to the right moment of extubation, up to 1 day. Yes
Secondary Central venous pressure(CVP) Central venous pressure(CVP) are monitored every 15 min from the induction of anesthesia to the right moment of extubation. From the induction of anesthesia to the right moment of extubation, up to 1 day. Yes
Secondary Blood pressure systolic blood pressure, Diastolic blood pressure are monitored every 15 min from the induction of anesthesia to the right moment of extubation. From the induction of anesthesia to the right moment of extubation, up to 1 day. Yes
Secondary Respiration rate Respiration rate are monitored every 15 min from the induction of anesthesia to the right moment of extubation. From the induction of anesthesia to the right moment of extubation, up to 1 day. Yes
Secondary Pulse blood oxygen saturation Pulse blood oxygen saturation are monitored every 15 min from the induction of anesthesia to the right moment of extubation. From the induction of anesthesia to the right moment of extubation, up to 1 day. Yes
Secondary Number of Participants with Serious and Non-Serious Adverse Events Up to 7 days Yes
See also
  Status Clinical Trial Phase
Completed NCT02710123 - Sub-Threshold Exercise Treatment for Adolescents With Sports Related Concussion N/A
Recruiting NCT02777060 - Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome Measures N/A
Completed NCT02262286 - MIND (Management of Traumatic Brain Injury Diagnosis) N/A
Completed NCT01461902 - Vasospasm in Pediatric Traumatic Brain Injury N/A
Recruiting NCT01198964 - Optimization of Human Cortical Stimulation
Active, not recruiting NCT01207050 - Effect of Rozerem on Sleep Among People With Traumatic Brain Injury Phase 4
Completed NCT00875329 - Traumatic Brain Injury (TBI) Screening Instruments N/A
Completed NCT01201863 - Neuroendocrine Dysfunction in Traumatic Brain Injury: Effects of Testosterone Therapy Phase 4
Completed NCT01059890 - Cerebral Antibiotics Distribution After Acute Brain Injury Phase 1
Completed NCT01035606 - Training in Goal-directed Attention Regulation for Individuals With Brain Injury N/A
Completed NCT00596765 - Neuropsychological Cognitive Behavioral Therapy for Patients With Acquired Brain Injury N/A
Completed NCT00571623 - Automated Chest Physiotherapy to Improve Outcomes in Neuro N/A
Completed NCT00336466 - The Erythropoietin NeuroProtective Effect: Assessment in CABG Surgery (TENPEAKS) Phase 2
Recruiting NCT05105763 - Biofeedback Gait Retraining for Stiff Knee Gait Correction N/A
Recruiting NCT02495558 - Cough Assessment in Patients With Severe Acquired Brain Injury N/A
Completed NCT02100592 - Early Verticalization in neuroICU With ERIGO: a Safety and Feasibility Study Phase 1/Phase 2
Completed NCT00797680 - Duration of Hypothermia for Neuroprotection After Pediatric Cardiac Arrest Phase 2
Completed NCT00018499 - Genotype Influence on Recovery After Traumatic Brain Injury N/A
Recruiting NCT02567201 - Electrophysiological Evaluation of Voluntary Attention N/A
Withdrawn NCT05581927 - Whole-Body Hypothermia for Neonates With Hypoxic-Ischemic Encephalopathy(HIE) N/A